24843404|t|GIP and GLP-1, the two incretin hormones: Similarities and differences.
24843404|a|Gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are the two primary incretin hormones secreted from the intestine on ingestion of glucose or nutrients to stimulate insulin secretion from pancreatic beta cells. GIP and GLP-1 exert their effects by binding to their specific receptors, the GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R), which belong to the G-protein coupled receptor family. Receptor binding activates and increases the level of intracellular cyclic adenosine monophosphate in pancreatic beta cells, thereby stimulating insulin secretion glucose-dependently. In addition to their insulinotropic effects, GIP and GLP-1 play critical roles in various biological processes in different tissues and organs that express GIPR and GLP-1R, including the pancreas, fat, bone and the brain. Within the pancreas, GIP and GLP-1 together promote beta cell proliferation and inhibit apoptosis, thereby expanding pancreatic beta cell mass, while GIP enhances postprandial glucagon response and GLP-1 suppresses it. In adipose tissues, GIP but not GLP-1 facilitates fat deposition. In bone, GIP promotes bone formation while GLP-1 inhibits bone absorption. In the brain, both GIP and GLP-1 are thought to be involved in memory formation as well as the control of appetite. In addition to these differences, secretion of GIP and GLP-1 and their insulinotropic effects on beta cells have been shown to differ in patients with type 2 diabetes compared to healthy subjects. We summarize here the similarities and differences of these two incretin hormones in secretion and metabolism, their insulinotropic action on pancreatic beta cells, and their non-insulinotropic effects, and discuss their potential in treatment of type 2 diabetes. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2010.00022.x, 2010). 
24843404	0	3	GIP	Gene	2695
24843404	8	13	GLP-1	Gene	2641
24843404	72	102	Gastric inhibitory polypeptide	Gene	2695
24843404	104	107	GIP	Gene	2695
24843404	113	136	glucagon-like peptide-1	Gene	2641
24843404	138	143	GLP-1	Gene	2641
24843404	227	234	glucose	Chemical	MESH:D005947
24843404	261	268	insulin	Gene	3630
24843404	307	310	GIP	Gene	2695
24843404	315	320	GLP-1	Gene	2641
24843404	385	397	GIP receptor	Gene	2696
24843404	399	403	GIPR	Gene	2696
24843404	413	427	GLP-1 receptor	Gene	2740
24843404	429	435	GLP-1R	Gene	2740
24843404	561	591	cyclic adenosine monophosphate	Chemical	MESH:D000242
24843404	638	645	insulin	Gene	3630
24843404	656	663	glucose	Chemical	MESH:D005947
24843404	722	725	GIP	Gene	2695
24843404	730	735	GLP-1	Gene	2641
24843404	833	837	GIPR	Gene	2696
24843404	842	848	GLP-1R	Gene	2740
24843404	920	923	GIP	Gene	2695
24843404	928	933	GLP-1	Gene	2641
24843404	1049	1052	GIP	Gene	2695
24843404	1075	1083	glucagon	Gene	2641
24843404	1097	1102	GLP-1	Gene	2641
24843404	1138	1141	GIP	Gene	2695
24843404	1150	1155	GLP-1	Gene	2641
24843404	1193	1196	GIP	Gene	2695
24843404	1227	1232	GLP-1	Gene	2641
24843404	1278	1281	GIP	Gene	2695
24843404	1286	1291	GLP-1	Gene	2641
24843404	1422	1425	GIP	Gene	2695
24843404	1430	1435	GLP-1	Gene	2641
24843404	1512	1520	patients	Species	9606
24843404	1526	1541	type 2 diabetes	Disease	MESH:D003924
24843404	1819	1834	type 2 diabetes	Disease	MESH:D003924
24843404	Bind	2695	2740
24843404	Positive_Correlation	MESH:D000242	2740
24843404	Association	MESH:D003924	2641
24843404	Bind	2641	2695
24843404	Bind	2641	2696
24843404	Association	MESH:D005947	2641
24843404	Positive_Correlation	2695	3630
24843404	Association	MESH:D003924	2695
24843404	Positive_Correlation	MESH:D005947	3630
24843404	Association	MESH:D005947	2695
24843404	Positive_Correlation	2641	3630
24843404	Bind	2641	2740
24843404	Bind	2695	2696

